Neuropace Inc
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable a… Read more
Neuropace Inc (NPCE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.105x
Based on the latest financial reports, Neuropace Inc (NPCE) has a cash flow conversion efficiency ratio of -0.105x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.94 Million) by net assets ($18.52 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Neuropace Inc - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Neuropace Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Neuropace Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neuropace Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ananti Inc
KQ:025980
|
0.033x |
|
Xiamen Hexing Packaging Printing Co Ltd
SHE:002228
|
0.041x |
|
Cosmoam&T
KO:005070
|
0.043x |
|
SEMAPA SGPS NAM. O.N.
STU:SQQ1
|
0.059x |
|
Chiyoda Corporation
PINK:CHYCF
|
N/A |
|
Suprajit Engineering Limited
NSE:SUPRAJIT
|
0.063x |
|
Zhongfu Information Inc
SHE:300659
|
-0.012x |
|
ECOVE Environment Corp
TWO:6803
|
-0.287x |
Annual Cash Flow Conversion Efficiency for Neuropace Inc (2019–2024)
The table below shows the annual cash flow conversion efficiency of Neuropace Inc from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $8.01 Million | $-17.95 Million | -2.240x | -134.83% |
| 2023-12-31 | $20.65 Million | $-19.70 Million | -0.954x | +10.03% |
| 2022-12-31 | $34.78 Million | $-36.87 Million | -1.060x | -217.06% |
| 2021-12-31 | $73.50 Million | $-24.58 Million | -0.334x | -328.75% |
| 2020-12-31 | $-147.83 Million | $-21.61 Million | 0.146x | -24.45% |
| 2019-12-31 | $-129.35 Million | $-25.03 Million | 0.193x | -- |